'Clinicaltrials gov' diaporamas de présentation

Small and Large-Molecule Angiogenesis Inhibitors: Excitement and Disappointments

Small and Large-Molecule Angiogenesis Inhibitors: Excitement and Disappointments . CT-322 VEGFR2 Adnectin. Cediranib VEGFR Kinase Inhibitor. Scott Kopetz, MD, PhD Gastrointestinal Medical Oncology University of Texas, M D Anderson Cancer Center. Outline.

750 views • 37 slides

Free Authoritative Health Websites

Free Authoritative Health Websites. Emily Vardell, MLS evardell@med.miami.edu http://www.delicious.com/FLAHealthLinks. MedlinePlus. http://medlineplus.gov/. MedlinePlus Searches. Health Topics in MedlinePlus. Population Groups. Gay, Lesbian and Transgender Health.

457 views • 34 slides

Presented to The Federal Big Data Working Group Meetup On 02 June 2014 By Chuck Rehberg, CTO

445 views • 34 slides

Change Can Happen: New Trends in Clinical Trials in the U.S.

Change Can Happen: New Trends in Clinical Trials in the U.S. Peter Lurie, MD, MPH Health Research Group at Public Citizen Presented at HAI Europe Open Seminar Neues Stadthaus, Berlin November 21, 2008. Outline. Ethics of developing country trials Access to data at the FDA Phase I GMPs

545 views • 33 slides

379 views • 27 slides

Meaningful Use Workgroup Subgroup 2 - Engaging Patients and Families May 13, 2013

431 views • 27 slides

Bivalirudin Versus Unfractionated Heparin in Biomarker Negative Patients With Stable and Unstable Angina Undergoing PCI

ClinicalTrials.gov Identifier NCT00262054. Bivalirudin Versus Unfractionated Heparin in Biomarker Negative Patients With Stable and Unstable Angina Undergoing PCI. ISAR-REACT 3.

657 views • 21 slides

PC Enzinger, BA Burtness, DR Hollis, D Niedzwiecki, DH Ilson, AB Benson 3rd,

CALGB 80403 / ECOG 1206: Randomized Phase II Study of Standard Chemotherapy + Cetuximab for Metastatic Esophageal Cancer. PC Enzinger, BA Burtness, DR Hollis, D Niedzwiecki, DH Ilson, AB Benson 3rd, RJ Mayer, RM Goldberg. CALGB 80403 / ECOG E1206: Background.

304 views • 21 slides

Oral Cilostazol Prevents Restenosis And Repeat Revascularization After Percutaneous Coronary Stenting: A Meta-Analysis Of 15 Randomized Trials And 4897 Patients. G. Biondi-Zoccai, 1 C. Moretti, 1 M. Lotrionte, 2 P. Agostoni, 3 F. Sciuto, 1

249 views • 18 slides

A service of the U.S. National Institutes of Health

A service of the U.S. National Institutes of Health. Module 1: Clinical Trials and Requirements for Registration and Results Reporting. What is a Clinical Study?. A research study using human subjects to evaluate the effect of interventions or exposures on biomedical or health-related outcomes.

320 views • 17 slides

Disclosures

Efficacy and Safety of Glycoprotein IIb/IIIa Inhibitors During Elective Coronary Revascularization A meta-analysis of randomized trials performed in the era of stents and thienopyridines Winchester DE, Wen X, Brearley WD, Park KE, Anderson RD, Bavry AA . Disclosures.

299 views • 15 slides

BILE DUCT

BILE DUCT. Regaining of function after recent passage of stones. Bile Duct. The common bile duct averages about 10 cm in length

508 views • 9 slides